Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MICHAEL JAMES SNYDER

Allopathic & Osteopathic Physicians Internal Medicine Pulmonary Disease

NPI
1457389132
CMS profile
111778
Location
INDIANAPOLIS, IN

General Payments · PY2018–2024

$13,249.35

  • Reported across 336 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$691.62

34 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $691.62 34

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $4,567.65 94
PY2019 $4,850.73 60
PY2020 $740.53 36
PY2021 $374.83 24
PY2022 $677.15 30
PY2023 $1,346.84 58
PY2024 $691.62 34

Payment records · PY2024 (34)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $21.61 01/16/2024 Food and Beverage Undisputed 01/23/2026 1116139306 CMS
Amgen Inc. $24.94 12/12/2024 Food and Beverage Undisputed 01/23/2026 1116139312 CMS
AstraZeneca Pharmaceuticals LP $13.32 08/27/2024 Food and Beverage Undisputed 01/23/2026 1105748079 CMS
Azurity Pharmaceuticals, Inc. $17.90 06/21/2024 Food and Beverage Undisputed 01/23/2026 1134013001 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $17.92 02/13/2024 Food and Beverage Undisputed 01/23/2026 1118016494 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $14.80 04/01/2024 Food and Beverage Undisputed 01/23/2026 1118016490 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $20.00 07/10/2024 Food and Beverage Undisputed 01/23/2026 1118016498 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $17.95 07/16/2024 Food and Beverage Undisputed 01/23/2026 1118016496 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $17.31 08/14/2024 Food and Beverage Undisputed 01/23/2026 1118016492 CMS
GENZYME CORPORATION $23.82 08/13/2024 Food and Beverage Undisputed 01/23/2026 1139800144 CMS
GlaxoSmithKline, LLC. $13.08 07/26/2024 Food and Beverage Undisputed 01/23/2026 1115756660 CMS
Grifols USA, LLC $16.35 03/18/2024 Food and Beverage Undisputed 01/23/2026 1124735427 CMS
Grifols USA, LLC $14.65 12/10/2024 Food and Beverage Undisputed 01/23/2026 1124735429 CMS
Janssen Biotech, Inc. $20.25 08/12/2024 Food and Beverage Undisputed 01/23/2026 1078622010 CMS
Mylan Specialty L.P. $17.69 02/14/2024 Food and Beverage Undisputed 01/23/2026 1147300915 CMS
Octapharma USA, Inc. $24.04 11/13/2024 Food and Beverage Undisputed 01/23/2026 1142319504 CMS
PFIZER INC. $19.29 01/17/2024 Food and Beverage Undisputed 01/23/2026 1130970637 CMS
Regeneron Healthcare Solutions, Inc. $18.61 04/03/2024 Food and Beverage Undisputed 01/23/2026 1114183216 CMS
Regeneron Healthcare Solutions, Inc. $19.92 10/08/2024 Food and Beverage Undisputed 01/23/2026 1114183224 CMS
Shionogi Inc $23.40 06/21/2024 Food and Beverage Undisputed 01/23/2026 1154337930 CMS
Takeda Pharmaceuticals U.S.A., Inc. $10.95 02/15/2024 Food and Beverage Undisputed 01/23/2026 1137679079 CMS
Takeda Pharmaceuticals U.S.A., Inc. $14.31 03/13/2024 Food and Beverage Undisputed 01/23/2026 1137679081 CMS
Takeda Pharmaceuticals U.S.A., Inc. $10.27 03/13/2024 Food and Beverage Undisputed 01/23/2026 1137679083 CMS
Takeda Pharmaceuticals U.S.A., Inc. $23.47 03/20/2024 Food and Beverage Undisputed 01/23/2026 1137679085 CMS
Takeda Pharmaceuticals U.S.A., Inc. $24.48 04/09/2024 Food and Beverage Undisputed 01/23/2026 1137679087 CMS
Takeda Pharmaceuticals U.S.A., Inc. $26.44 06/19/2024 Food and Beverage Undisputed 01/23/2026 1137679089 CMS
Takeda Pharmaceuticals U.S.A., Inc. $105.21 08/14/2024 Food and Beverage Undisputed 01/23/2026 1137679091 CMS
Takeda Pharmaceuticals U.S.A., Inc. $13.72 08/14/2024 Food and Beverage Undisputed 01/23/2026 1137679093 CMS
Takeda Pharmaceuticals U.S.A., Inc. $4.62 08/14/2024 Food and Beverage Undisputed 01/23/2026 1137679095 CMS
Takeda Pharmaceuticals U.S.A., Inc. $18.54 09/11/2024 Food and Beverage Undisputed 01/23/2026 1137679097 CMS
Takeda Pharmaceuticals U.S.A., Inc. $33.31 10/10/2024 Food and Beverage Undisputed 01/23/2026 1137679099 CMS
Takeda Pharmaceuticals U.S.A., Inc. $11.08 10/22/2024 Food and Beverage Undisputed 01/23/2026 1137679101 CMS
Takeda Pharmaceuticals U.S.A., Inc. $0.27 10/22/2024 Food and Beverage Undisputed 01/23/2026 1137679103 CMS
Takeda Pharmaceuticals U.S.A., Inc. $18.10 12/12/2024 Food and Beverage Undisputed 01/23/2026 1137679105 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.